Literature DB >> 18094269

Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.

Yoshiki Asayama1, Kengo Yoshimitsu, Yunosuke Nishihara, Hiroyuki Irie, Shinichi Aishima, Akinobu Taketomi, Hiroshi Honda.   

Abstract

OBJECTIVE: The objective of our study was to clarify the sequential changes of arterial blood supply during the development of hepatocellular carcinoma (HCC) with an emphasis on its late stage.
MATERIALS AND METHODS: Sixty HCC nodules were confirmed at pathology in 59 patients who had undergone CT hepatic arteriography and CT during arterioportography (CTAP). Lesions were classified into one of the four groups: group 1, nodules that appeared to show preserved portal perfusion on CTAP and showed hypo- or isoattenuation on CT hepatic arteriography; group 2, very hyperattenuating on CT hepatic arteriography; group 3, hyperattenuating on CT hepatic arteriography; and group 4, hypo- or isoattenuating on CT hepatic arteriography. Groups 2, 3, and 4 showed the portal perfusion defect on CTAP. These hemodynamic patterns were compared among different histologic grades. We also examined the number of unpaired arteries and the Ki-67 labeling index of the tumor pathologically.
RESULTS: The numbers of lesions in each group were as follows for groups 1, 2, 3, and 4, respectively: 17, one, two, and 0 well-differentiated HCCs; 0, 10, nine, and one moderately differentiated HCC; and 0, three, 12, and five poorly differentiated HCCs. The lesions showed significantly different hemodynamic patterns among different histologic grades (Cramer's V = 0.6919, p < 0.0001). The number of unpaired arteries showed a strong correlation with Ki-67 labeling index in well-differentiated HCC and moderately differentiated HCC (rho = 0.673, p < 0.0001) and a moderate inverse correlation with Ki-67 labeling index in poorly differentiated HCC (rho = -0.540, p = 0.0185).
CONCLUSION: In the late stage of HCC development, the arterial blood supply significantly decreases as the histologic grade progresses.

Entities:  

Mesh:

Year:  2008        PMID: 18094269     DOI: 10.2214/AJR.07.2117

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  43 in total

1.  Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and histological grading.

Authors:  X Q Pei; L Z Liu; M Liu; W Zheng; F Han; A H Li; M Y Cai
Journal:  Br J Radiol       Date:  2011-11-17       Impact factor: 3.039

2.  Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI.

Authors:  Chansik An; Mi-Suk Park; Hyae-Min Jeon; Yeo-Eun Kim; Woo-Suk Chung; Yong Eun Chung; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2012-03-22       Impact factor: 5.315

3.  Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree.

Authors:  Annarita Pecchi; Giulia Besutti; Mario De Santis; Cinzia Del Giovane; Sofia Nosseir; Giuseppe Tarantino; Fabrizio Di Benedetto; Pietro Torricelli
Journal:  World J Hepatol       Date:  2015-02-27

4.  Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging.

Authors:  Weihua Guo; Suhong Zhao; Yuhai Yang; Guangrui Shao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Yuichiro Kubo; Shinichi Aishima; Ken Shirabe; Takashi Yoshiura; Hiroshi Honda
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

Review 6.  Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis.

Authors:  Khaled Y Elbanna; Ania Z Kielar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 7.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

8.  Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.

Authors:  Sharon W Kwan; Nicholas Fidelman; Elizabeth Ma; Robert K Kerlan; Francis Y Yao
Journal:  Liver Transpl       Date:  2012-06       Impact factor: 5.799

9.  CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.

Authors:  Akihiro Nishie; Kengo Yoshimitsu; Daisuke Okamoto; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Tomohiro Nakayama; Yukihisa Takayama; Ken Shirabe; Nobuhiro Fujita; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2012-10-17       Impact factor: 2.374

10.  Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: comparison with pathological differentiation.

Authors:  J H Lee; J M Lee; S J Kim; J H Baek; S H Yun; K W Kim; J K Han; B I Choi
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.